MedPath

Simcha Il 18, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Phase 1
Recruiting
Conditions
Cancer
Squamous Cell Carcinoma of the Head and Neck
Non Small Cell Lung Cancer
Renal Cell Carcinoma
MSI-High
Solid Tumor
Carcinoma
Melanoma
Triple-negative Breast Cancer
Interventions
First Posted Date
2021-03-08
Last Posted Date
2024-11-15
Lead Sponsor
Simcha IL-18, Inc.
Target Recruit Count
316
Registration Number
NCT04787042
Locations
🇺🇸

HonorHealth Research Institute, Scottsdale, Arizona, United States

🇺🇸

Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States

🇺🇸

Yale Cancer Center, New Haven, Connecticut, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.